Search research articles
Contact Us
Filters
Showing results (641-650 of 672) with videos related to
Page
of 68
Sort By:
Journal of the American College of Surgeons
|
July 5, 2015
Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Kozo Yoshikawa, Mitsuo Shimada, Go Wakabayashi, et al.
International Journal of Clinical Oncology
|
May 16, 2019
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)
Toshikazu Moriwaki, Yoshinori Sakai, Hiroyasu Ishida, et al.
Liver Cancer
|
November 11, 2024
Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023
Keiichi Akahoshi, Junichi Shindoh, Minoru Tanabe, et al.
Surgery Today
|
August 10, 2022
Impact of the hospital volume and setting on postoperative complications of surgery for gastroenterological cancers in a regional area of Western Japan
Susumu Kunisawa, Haku Ishida, Hiroshi Ikai, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
February 13, 2014
Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Takahiro Uenishi, Shunichi Ariizumi, Taku Aoki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 25, 2016
Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study
Yasushi Sato, Hiroyuki Ohnuma, Takayuki Nobuoka, et al.
Liver Cancer
|
August 1, 2025
A Newly Launched Nationwide Database Revealed Real-World Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE)
Yoshinari Asaoka, Ryosuke Tateishi, Yasuhide Yamada, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
December 7, 2010
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Kazuhisa Uchiyama, Masakazu Yamamoto, Hiroki Yamaue, et al.
Clinical Colorectal Cancer
|
January 19, 2016
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)
Tomohiro Nishina, Toshikazu Moriwaki, Mitsuo Shimada, et al.
Japanese Journal of Clinical Oncology
|
April 26, 2022
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years
Toshikazu Moriwaki, Tomohiro Nishina, Yoshinori Sakai, et al.
Page
of 68
Search research articles
Search
Showing results (641-650 of 672) with videos related to
Sort By:
Page
of 68
Journal of the American College of Surgeons
|
July 5, 2015
Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Kozo Yoshikawa, Mitsuo Shimada, Go Wakabayashi, et al.
International Journal of Clinical Oncology
|
May 16, 2019
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)
Toshikazu Moriwaki, Yoshinori Sakai, Hiroyasu Ishida, et al.
Liver Cancer
|
November 11, 2024
Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023
Keiichi Akahoshi, Junichi Shindoh, Minoru Tanabe, et al.
Surgery Today
|
August 10, 2022
Impact of the hospital volume and setting on postoperative complications of surgery for gastroenterological cancers in a regional area of Western Japan
Susumu Kunisawa, Haku Ishida, Hiroshi Ikai, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
February 13, 2014
Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Takahiro Uenishi, Shunichi Ariizumi, Taku Aoki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 25, 2016
Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study
Yasushi Sato, Hiroyuki Ohnuma, Takayuki Nobuoka, et al.
Liver Cancer
|
August 1, 2025
A Newly Launched Nationwide Database Revealed Real-World Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE)
Yoshinari Asaoka, Ryosuke Tateishi, Yasuhide Yamada, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
December 7, 2010
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Kazuhisa Uchiyama, Masakazu Yamamoto, Hiroki Yamaue, et al.
Clinical Colorectal Cancer
|
January 19, 2016
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)
Tomohiro Nishina, Toshikazu Moriwaki, Mitsuo Shimada, et al.
Japanese Journal of Clinical Oncology
|
April 26, 2022
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years
Toshikazu Moriwaki, Tomohiro Nishina, Yoshinori Sakai, et al.
Page
of 68